Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01170117 · ClinicalTrials.gov registry record · NA
Olanzapine Versus Placebo for Outpatients With Anorexia Nervosa
A NA study, sponsored by New York State Psychiatric Institute.
- Completed
- Registry status
- NA
- Development phase
- 152
- Enrollment target
NCT01170117 is a NA study that has completed, run by New York State Psychiatric Institute. The registered enrollment target is 152 participants.
The verdict
NCT01170117, a NA study, has completed, sponsored by New York State Psychiatric Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 152 participants
- Enrollment target
Study Summary
Anorexia Nervosa (AN) is a serious illness associated with substantial morbidity and mortality. Weight restoration is a treatment priority, and better treatments are needed.
Interventions
- DRUG Placebo
- DRUG Olanzapine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 152 participants |
| Start Date | 2010-08 |
| Est. Completion | 2017-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01170117
The ClinicalTrials.gov registry entry for NCT01170117 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 152 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is New York State Psychiatric Institute, which has 364 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01170117 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01170117 about?
NCT01170117 is a clinical study titled "Olanzapine Versus Placebo for Outpatients With Anorexia Nervosa". Anorexia Nervosa (AN) is a serious illness associated with substantial morbidity and mortality. Weight restoration is a treatment priority, and better treatments are needed.
What is the current status of trial NCT01170117?
This trial is currently completed. It is a NA study. The enrollment target is 152 participants. The study started on 2010-08. Estimated completion is 2017-06.
What interventions are being tested in trial NCT01170117?
The interventions under investigation include: Placebo (DRUG), Olanzapine (DRUG).
Who is sponsoring clinical trial NCT01170117?
This trial is sponsored by New York State Psychiatric Institute, which has 364 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.